SF0426OA6643/072026
13/07/2028
Active ingredient:
0.25 mg oxymetazoline hydrochloride
Therapeutic indications:
Indicated for nasal obstruction in acute rhinitis and sinusitis. Supportive treatment for otitis media and allergic rhinitis suctioning difficulties in newborns and infants as a result of nasal obstruction.
Dosage form
Drops.
Active ingredient:40 mg Esomeprazole Therapeutic indications: Indicated for gastro-oesophageal Reflux...
Read More
Active ingredient:20 mg Esomeprazole Therapeutic indications: Indicated for gastro-oesophageal Reflux...
Read More
Active ingredient:20 mg/g Sertaconazole. Therapeutic indications:Indicated for the topical...
Read More
Factory Locations
Quick Links
© 2024 All rights reserved @PHARO PHARMA
Terms and Conditions | Privacy Policy
